Valery F. Mikhalchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valery F. Mikhalchenko has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- A. T. Yakovlev
Volgograd State Medical University
2 shared publications - Irina V. Firsova
Volgograd State Medical University
2 shared publications - Alexandra Popova
Volgograd State Medical University
1 shared publication - Danilina T.F.
Volgograd State Medical University
1 shared publication - Dorozhkina E.G.
Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russian Federation
1 shared publication - Sergej Krajnov
The Volgograd State Medical University
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (3) , 33-37
Experience with the use of the tacrolimus in the treatment of lichen planus of the oral mucosa
Lichen planus is one of the most common dermatoses affecting the skin and mucous membranes. The predominant hypothesis for the etiology and pathogenesis of this disease is a T-lymphocyte-mediated autoimmune process involving basal keratinocytes. Therefore, when selecting and optimizing therapy for patients with lichen planus, it is essential to use medications that suppress the production and release of inflammatory cytokines. However, most medications used for topical therapy exhibit poor adhesion to mucous membranes, which reduces their therapeutic effect and, consequently, their effectiveness. The use of mucoadhesive agents as a drug delivery system and prolongation of action allows for the optimization of topical therapy for oral mucosal lesions. Therefore, the search for adequate treatments and methods for dermatoses manifesting on the oral mucosa is a pressing issue in dental practice. The aim of this study was to evaluate the effectiveness of the tacrolimus as part of Tacropic® in the treatment of lichen planus with oral mucosal lesions. Research methodology: This article presents the experience of treating 14 patients with erosive and ulcerative lichen planus using Tacropic® 0.03 % and Tizol® mucoadhesive gel in their standard drug therapy. Patients were monitored for one month, with results recorded at follow-up intervals. Good tolerability of topical medications was observed. The results of the research: Perifocal edema, hyperemia, bleeding, and pain subsided by day 7. Complete epithelialization of erosions was achieved in 71 % (14) of patients by day 14. By the end of the clinical observation period, clinical stabilization was achieved in all patients. Conclusions: These results in treating patients with oral lichen planus may serve as a basis for further research and potential use of topical agents in dentistry.
- 15 October 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (3) , 33-37
Open AccessExperience with the use of the tacrolimus in the treatment of lichen planus of the oral mucosa
Lichen planus is one of the most common dermatoses affecting the skin and mucous membranes. The predominant hypothesis for the etiology and pathogenesis of this disease is a T-lymphocyte-mediated autoimmune process involving basal keratinocytes. Therefore, when selecting and optimizing therapy for patients with lichen planus, it is essential to use medications that suppress the production and release of inflammatory cytokines. However, most medications used for topical therapy exhibit poor adhesion to mucous membranes, which reduces their therapeutic effect and, consequently, their effectiveness. The use of mucoadhesive agents as a drug delivery system and prolongation of action allows for the optimization of topical therapy for oral mucosal lesions. Therefore, the search for adequate treatments and methods for dermatoses manifesting on the oral mucosa is a pressing issue in dental practice. The aim of this study was to evaluate the effectiveness of the tacrolimus as part of Tacropic® in the treatment of lichen planus with oral mucosal lesions. Research methodology: This article presents the experience of treating 14 patients with erosive and ulcerative lichen planus using Tacropic® 0.03 % and Tizol® mucoadhesive gel in their standard drug therapy. Patients were monitored for one month, with results recorded at follow-up intervals. Good tolerability of topical medications was observed. The results of the research: Perifocal edema, hyperemia, bleeding, and pain subsided by day 7. Complete epithelialization of erosions was achieved in 71 % (14) of patients by day 14. By the end of the clinical observation period, clinical stabilization was achieved in all patients. Conclusions: These results in treating patients with oral lichen planus may serve as a basis for further research and potential use of topical agents in dentistry.
- 19 December 2020
- Published by Periodontal Association - RPA in Parodontologiya
- Vol. 25 (4) , 295-300
Diagnostic information content of indicators of cytokine profile of gingival fluid in pregnant women with iron deficiency anemia
Relevance. Modern literature and clinical dental practice do not provide enough information about the value of local immunity parameters for early diagnosis of inflammatory periodontal diseases in pregnant women with iron deficiency anemia. Conventional anti-inflammatory medications used to treat inflammatory periodontal disease are frequently contraindicated during pregnancy. It is important to make a reasonable choice of safe medications, prevention methods, and treatment at early stages of inflammatory periodontal diseases in pregnant women with iron deficiency anemia. The aim of the present study is to determine informative cytokine levels in gingival fluid for early diagnosis of inflammatory periodontal disease and evaluation of effectiveness of “Lysobact” medication in pregnant women with iron deficiency anemia (IDA).Materials and methods. Cytokine levels (IL-8, IL-10; IgA, IgG) in gingival crevicular fluid were investigated in 46 pregnant women aged 18-35: among them 16 (n = 16) had mild IDA (D50), 15 (n = 15) didn't have IDA, 15 (n = 15) were non-pregnant controls. «Lysobact» (Reg. #ПN0179/01-2002) was used in pregnant women with IDA; conventional antiinflammatory therapy was used to treat pregnant women without IDA, before and after drug therapy (8-10 days) according to clinical examinations.Results. There was determined diagnostic value of cytokine levels (IgA, IgG; IL-8, IL-10) that are of great importance for early diagnosis, evaluation of the course of the disease and effectiveness of “Lysobact” immunomodulating drug, and that significantly increase in pregnant women with IDA (IL-10 from 0.010 [1.790] to 3.050 [8.550] ng/ml) versus pregnant women without IDA (from 0.001 [1.259] to 2.900 [18.640] ng/ml) in comparison with controls (4.5 [1.13] ng/ml).Conclusion. Clinical laboratory results in pregnant women with inflammatory periodontal disease allowed to determine diagnostic value of gingival crevicular fluid parameters (sIgA, IgG; IL-8, IL-10) that are related to clinical periodontal index levels, and are informative non-invasive method and are of practical importance for early diagnosis of inflammatory periodontal disease and effectiveness of “Lysobact” drug in pregnant women with iron deficiency anemia.
- 19 December 2020
- Published by Periodontal Association - RPA in Parodontologiya
- Vol. 25 (4) , 295-300
Diagnostic information content of indicators of cytokine profile of gingival fluid in pregnant women with iron deficiency anemia
Relevance. Modern literature and clinical dental practice do not provide enough information about the value of local immunity parameters for early diagnosis of inflammatory periodontal diseases in pregnant women with iron deficiency anemia. Conventional anti-inflammatory medications used to treat inflammatory periodontal disease are frequently contraindicated during pregnancy. It is important to make a reasonable choice of safe medications, prevention methods, and treatment at early stages of inflammatory periodontal diseases in pregnant women with iron deficiency anemia. The aim of the present study is to determine informative cytokine levels in gingival fluid for early diagnosis of inflammatory periodontal disease and evaluation of effectiveness of “Lysobact” medication in pregnant women with iron deficiency anemia (IDA).Materials and methods. Cytokine levels (IL-8, IL-10; IgA, IgG) in gingival crevicular fluid were investigated in 46 pregnant women aged 18-35: among them 16 (n = 16) had mild IDA (D50), 15 (n = 15) didn't have IDA, 15 (n = 15) were non-pregnant controls. «Lysobact» (Reg. #ПN0179/01-2002) was used in pregnant women with IDA; conventional antiinflammatory therapy was used to treat pregnant women without IDA, before and after drug therapy (8-10 days) according to clinical examinations.Results. There was determined diagnostic value of cytokine levels (IgA, IgG; IL-8, IL-10) that are of great importance for early diagnosis, evaluation of the course of the disease and effectiveness of “Lysobact” immunomodulating drug, and that significantly increase in pregnant women with IDA (IL-10 from 0.010 [1.790] to 3.050 [8.550] ng/ml) versus pregnant women without IDA (from 0.001 [1.259] to 2.900 [18.640] ng/ml) in comparison with controls (4.5 [1.13] ng/ml).Conclusion. Clinical laboratory results in pregnant women with inflammatory periodontal disease allowed to determine diagnostic value of gingival crevicular fluid parameters (sIgA, IgG; IL-8, IL-10) that are related to clinical periodontal index levels, and are informative non-invasive method and are of practical importance for early diagnosis of inflammatory periodontal disease and effectiveness of “Lysobact” drug in pregnant women with iron deficiency anemia.
- 16 May 2020
- Published by Periodontal Association - RPA in Parodontologiya
- Vol. 25 (2) , 101-107
More on the interpretationof gingival bleeding index in gerontodentistry
Relevance. Symptom of bleeding in elderly age has a number of features of its manifestation, not fully associated with the severity of gingivitis and periodontitis. It is associated withpolymorbidity, polypragmasy, age-dependent involutional processes, as well as with immune system aging.Purpose. To study the influence of confounders on the interpretation of the gingival bleeding index in elderly patients with periodontitis.Materials and methods. The clinical and laboratory examination of 64 elderly patients with chronic generalized periodontitis, divided into 2 clinical groups, was conducted. The conventional treatment was administered in both patient groups. The patients in the second cohort, along with other medications, received Polyoxidonium.Each clinical group was divided into two subgroups: “a” and “b” (depending on the NSIADintake). The comparison group was also formed.It consisted of 25 patients of middle age with a similar degree of periodontitis. To assess the bleeding symptom, the Mühlemann-Cowell (1975) bleeding index was determined, as well as its reduction (%). The study of local immunity included gingival fluid sampling andestimation of IL-1β and IL-10 concentration (pg / ml). Clinical and laboratory examination of patients was carried out within the time constraints: before the start of treatment, after 7, 14, 21, and 30 days.Results. During the initial examination and statistical analysis of the bleeding index mean values in elderly patients, higher values of the coefficient of variation were found (25.07%) than in the comparison group (16.24%).It confirmed the influence of confounders over this indicator.Moreover, before treatment, in both groups, significant differences between subgroups remained (which verified the effect of non-steroidal anti-inflammatory drugs), which disappeared in the subsequent stages of the examination. In further periods of observation, a decrease in the bleeding index was found, as well as the concentration of cytokines, and in the 2nd group, these indicators were statistically significantly lower than in the 1st (p < 0.05).Conclusion. The study showed a more significanthaemostatic effect of immunomodulation compared with conventional treatment. When analyzing bleeding index in elderly patients, confounders must be considered, otherwise, the findings, which do not fully correspond to the level of inflammation in the marginal periodontium, will be incorrectly interpreted.
- 16 May 2020
- Published by Periodontal Association - RPA in Parodontologiya
- Vol. 25 (2) , 101-107
More on the interpretationof gingival bleeding index in gerontodentistry
Relevance. Symptom of bleeding in elderly age has a number of features of its manifestation, not fully associated with the severity of gingivitis and periodontitis. It is associated withpolymorbidity, polypragmasy, age-dependent involutional processes, as well as with immune system aging.Purpose. To study the influence of confounders on the interpretation of the gingival bleeding index in elderly patients with periodontitis.Materials and methods. The clinical and laboratory examination of 64 elderly patients with chronic generalized periodontitis, divided into 2 clinical groups, was conducted. The conventional treatment was administered in both patient groups. The patients in the second cohort, along with other medications, received Polyoxidonium.Each clinical group was divided into two subgroups: “a” and “b” (depending on the NSIADintake). The comparison group was also formed.It consisted of 25 patients of middle age with a similar degree of periodontitis. To assess the bleeding symptom, the Mühlemann-Cowell (1975) bleeding index was determined, as well as its reduction (%). The study of local immunity included gingival fluid sampling andestimation of IL-1β and IL-10 concentration (pg / ml). Clinical and laboratory examination of patients was carried out within the time constraints: before the start of treatment, after 7, 14, 21, and 30 days.Results. During the initial examination and statistical analysis of the bleeding index mean values in elderly patients, higher values of the coefficient of variation were found (25.07%) than in the comparison group (16.24%).It confirmed the influence of confounders over this indicator.Moreover, before treatment, in both groups, significant differences between subgroups remained (which verified the effect of non-steroidal anti-inflammatory drugs), which disappeared in the subsequent stages of the examination. In further periods of observation, a decrease in the bleeding index was found, as well as the concentration of cytokines, and in the 2nd group, these indicators were statistically significantly lower than in the 1st (p < 0.05).Conclusion. The study showed a more significanthaemostatic effect of immunomodulation compared with conventional treatment. When analyzing bleeding index in elderly patients, confounders must be considered, otherwise, the findings, which do not fully correspond to the level of inflammation in the marginal periodontium, will be incorrectly interpreted.